Fresh analysis indicates that patients who stop using popular weight-loss injections like Wegovy and Mounjaro may regain lost weight far faster than those who halt conventional lifestyle regimens.
Published data in a major medical journal demonstrates that while obese individuals can lose a large proportion of their body weight while on the medication, the mass is regained at an average rate of 0.8 kg per month once they quit.
"Individuals buying these medications should be cognizant of the potential of rapid weight regain when the therapy ends," stated lead investigator Dr. Susan Jebb.
This pace of recovery implies a return to starting mass within about a year and a half.
Comparing Treatments
The research, which looked at 37 of trials involving over 9,000 of patients, compared the results of these new drugs with conventional dieting.
Scientists note that individuals who shed pounds through lifestyle changes alone usually experience a more gradual creep back—around 100 grams monthly—post-intervention.
Understanding the Rapid Rebound
Experts believe the way of the drugs is key to understanding the amplified regain.
GLP-1 drugs imitate a body's own chemical called glucagon-like peptide-1, which controls appetite.
"Long-term administration of the hormone concentrations far above than normal might result in the body to generate a reduced amount of its own natural hormone, and may also lessen responsiveness to its effects," noted Dr. Adam Collins, a nutrition specialist.
"Withdrawal of this GLP-1 'fix' results in appetite is unsuppressed, making binge eating far more likely."
A Lifelong Issue?
The NHS advise the injections for individuals with weight-linked health risks, accompanied by prescribed diet and exercise modifications.
Professionals say that, considering the high risk of relapse, the therapy is often long-term.
This perspective is supported by drug manufacturers, who state that the findings "underscore the long-term nature of obesity," comparing it to managing diseases like diabetes.
Patient Accounts
People who have stopped the medication report a intense resurgence of appetite.
"It felt as if a trigger that goes on and you become starving," recalled a patient.
This difficulty is exacerbated if patients have not developed sustainable dietary or behavioural modifications during treatment.
Growing Interest
Survey data suggest that millions of adults in the UK have tried these injections in the last 12 months, with demand remaining high.
- Adoption is greater among females compared to males.
- The 40s and 50s demographic shows the highest usage rates.
- A large proportion obtain the medications through private healthcare rather than public health services.
Finally, researchers caution that while the jabs are powerful agents for weight loss, they are not a permanent solution and maintained weight loss likely depends on combined lifestyle management.